PSMA-PET scans detect metastatic illness in 46% of sufferers with high-risk nonmetastatic hormone-sensitive prostate most cancers, revealing understaging by standard imaging.Amongst sufferers with...
March is Myeloma Consciousness Month, a time to acknowledge the refined however severe signs of a number of myeloma, together with persistent fatigue,...
The potential Meals and Drug Administration approval of Ordspono (odronextamab) for relapsed or refractory follicular lymphoma (FL) was mentioned by Dr. Deepa Jagadeesh,...
Blue gentle cystoscopy considerably reduces the chance of recurrence in sufferers with high-risk bladder most cancers in comparison with white gentle cystoscopy.Amongst sufferers...
